Anannya Bandyopadhyay

This study identifies 59 outer membrane β-barrel proteins from B. mallei and constructs a multi-epitope vaccine predicted to induce strong immune responses.

This study identifies and characterizes OMBB proteins in P. multocida, designs a multi-epitope vaccine, and predicts its immunogenicity and structural properties.

The paper models the molecular structure of Chlamydia trachomatis T3SS and identifies FDA-approved drugs that target CdsN ATPase oligomerization for antivirulence therapy.

This study models the T4SS structure of Brucella melitensis and identifies three FDA-approved drugs that could target the system for anti-virulence therapy.

This study uses computational methods to model and analyze outer membrane proteins in Brucella melitensis, identifying novel structures and interactions relevant to disease mechanisms.

The paper designs a multi-epitope vaccine using β-barrel outer membrane proteins from Chlamydia trachomatis, showing it is antigenic, non-allergenic, and capable of strong immune response through TLR4 binding.

The paper computationally identifies and characterizes 42 outer membrane beta-barrel proteins in Brachyspira pilosicoli, revealing their potential roles in virulence and disease.